EndoPredict (EPclin) Shown in Second Study to be More Effective than Oncotype DX® (RS) in Women with Intermediate Risk of Breast Cancer Recurrence

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice

Anil Bhaskar
Unified Customer Experience

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

Mike Viscel
Increasing Engagement

Thomas Shea
Programmatic Marketing

Frank X. Powers
Healthcare Challenger Brands

Laura Blair
Medication Adherence

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement